Regulatory Clearances Support Glaukos' Plans to Advance and Accelerate its Interventional Glaucoma Initiatives Globally Marks ...

You might be used to slathering on sunscreen to protect your skin, but have you been protecting your eyes as well? We only ...

Krystal Biotech rises 4% after dosing begins in a phase III study of KB803 eye drops to treat rare DEB-related corneal damage ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today ...

Topline data were announced from a phase 3 trial evaluating ST-100 ophthalmic solution for the treatment of dry eye disease.

Glaukos Q1 results beat expectations, and the company is delivering on a robust pipeline as it continues to build an ...

Perimenopause, or menopausal transition, marks the gradual shift in a woman’s reproductive life when hormone levels, ...

One of the early warning signs of high cholesterol can often be detected during a routine eye exam. Your optician may notice ...